IT1189091B - Eteri del 7-ossabicicloeptano sostituiti quali analoghi di composizioni farmaceutiche - Google Patents

Eteri del 7-ossabicicloeptano sostituiti quali analoghi di composizioni farmaceutiche

Info

Publication number
IT1189091B
IT1189091B IT20208/86A IT2020886A IT1189091B IT 1189091 B IT1189091 B IT 1189091B IT 20208/86 A IT20208/86 A IT 20208/86A IT 2020886 A IT2020886 A IT 2020886A IT 1189091 B IT1189091 B IT 1189091B
Authority
IT
Italy
Prior art keywords
oxabicycleptane
analogs
ethers
substituted
pharmaceutical compositions
Prior art date
Application number
IT20208/86A
Other languages
English (en)
Other versions
IT8620208A0 (it
IT8620208A1 (it
Inventor
Steven E Hall
Han Wen-Ching
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IT8620208A0 publication Critical patent/IT8620208A0/it
Publication of IT8620208A1 publication Critical patent/IT8620208A1/it
Application granted granted Critical
Publication of IT1189091B publication Critical patent/IT1189091B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IT20208/86A 1985-04-26 1986-04-24 Eteri del 7-ossabicicloeptano sostituiti quali analoghi di composizioni farmaceutiche IT1189091B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/727,965 US4608386A (en) 1985-04-26 1985-04-26 7-oxabicycloheptane ethers useful in the treatment of thrombotic diseases

Publications (3)

Publication Number Publication Date
IT8620208A0 IT8620208A0 (it) 1986-04-24
IT8620208A1 IT8620208A1 (it) 1987-10-24
IT1189091B true IT1189091B (it) 1988-01-28

Family

ID=24924854

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20208/86A IT1189091B (it) 1985-04-26 1986-04-24 Eteri del 7-ossabicicloeptano sostituiti quali analoghi di composizioni farmaceutiche

Country Status (7)

Country Link
US (1) US4608386A (it)
JP (1) JPS61257988A (it)
CA (1) CA1249290A (it)
DE (1) DE3613719A1 (it)
FR (1) FR2581066B1 (it)
GB (1) GB2174394B (it)
IT (1) IT1189091B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001506970A (ja) * 1996-09-06 2001-05-29 イーライ・リリー・アンド・カンパニー 方法及び新規な中間体
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
DE10164594A1 (de) 2001-12-21 2003-07-03 Bellheimer Metallwerk Gmbh Umlauf-Lagersystem
JP4766856B2 (ja) * 2004-08-31 2011-09-07 ダイセル化学工業株式会社 酸素原子含有多環式化合物、重合性組成物及びその硬化物
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
EP0045118B1 (en) * 1979-01-05 1984-04-04 National Research Development Corporation Intermediates for the synthesis of bicyclo (2,2,1) heptanes and bicyclo (2,2,1) hept-2z-enes
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA829068B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
US4416896A (en) * 1982-05-17 1983-11-22 E. R. Squibb & Sons, Inc. 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease
CA1256887A (en) * 1983-03-14 1989-07-04 Steven E. Hall 7-oxabicycloheptane substituted prostaglandin analogs
US4474803A (en) * 1983-03-14 1984-10-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted thio prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction

Also Published As

Publication number Publication date
FR2581066B1 (fr) 1989-02-24
IT8620208A0 (it) 1986-04-24
DE3613719A1 (de) 1986-10-30
CA1249290A (en) 1989-01-24
GB2174394B (en) 1988-11-30
IT8620208A1 (it) 1987-10-24
JPS61257988A (ja) 1986-11-15
US4608386A (en) 1986-08-26
GB2174394A (en) 1986-11-05
FR2581066A1 (fr) 1986-10-31
GB8610058D0 (en) 1986-05-29

Similar Documents

Publication Publication Date Title
IT1143056B (it) Procedimento per la produzione di interferon di tipo ii e composizioni farmaceutiche che lo contengono
IT1214683B (it) Composizioni farmaceutiche nasali
IT1194748B (it) Composizioni farmaceutiche per il trattamento di osteopatie
AU2199283A (en) Pharmaceutical compositions of m-chloro-alpha-t- butylaminopropiophenone
IT1189091B (it) Eteri del 7-ossabicicloeptano sostituiti quali analoghi di composizioni farmaceutiche
IT1200099B (it) Composizioni farmaceutiche somministrabili per via nasale
IL71184A0 (en) 7-oxabicycloheptane substituted prostaglandin analogs and pharmaceutical compositions containing the same
IT1156105B (it) Composizioni farmaceutiche per il trattamento della pelle
MX9203642A (es) Compuestos substituidos del acido 1,3,4,9-tetrahidropirano (3,4-b)-indol-1-acetico y composiciones farmaceuticas que los contienen.
IT1132510B (it) Composizioni farmaceutiche contenenti estratti di edera rampicante
IT1192286B (it) Procedimento per la preparazione di composti del piombo
IT1162463B (it) Procedimento per la preparazione di cefalosporine e composizioni farmaceutiche che le contengono e prodotto ottenuto
IT1203746B (it) Procedimento per la preparazione di derivati dello stilbene
IT1204314B (it) Analoghi di tioprostaglandina 7-ossabicicloeptano sostituiti
AU557513B2 (en) Pharmaceutical compositions of spiro-germanium compounds
IT1204769B (it) Analoghi di ossaprostaglandina 7-ossabicicloeptano sostituiti
IL56404A (en) Analogs of beta h-endorphin,their preparation and pharmaceutical compositions containing them
IT8448827A0 (it) Procedimento per la preparazione di antibiotici del tipo cefalosporina
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
IT1197844B (it) Composizione per il miglioramento del candeggio
IT1095388B (it) Composizione farmaceutica per la somministrazione di pancreatina
IT1190409B (it) Derivati della piridina,procedimento per la loro preparazione di composizioni terapeutiche contenenti detti derivati
PT88551A (pt) Process for the preparation of curable compositions suitable for use as sealants
IT1235761B (it) Derivati biciclici del catecolo, procedimento per la loro preparazione e composizioni terapeutiche che li contengono
IT8349055A0 (it) B-osso-l-carbammoil-pirrolpropionitrile, procedimento per la loro produzione, preparati farmaceutici con tenenti questi composti, nonche' il loro impiego terapeutico